Prostate cancer is the second-leading cause of cancer death in American men.About 1 in 8 men will be diagnosed with prostate ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) has been dosed ...

Andre Esteva, PhD, is an AI scientist, entrepreneur, and CEO of ArteraAI, revolutionizing cancer therapy through personalized diagnostics. A globally recognized ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple ...

Can PSA derivatives reduce unnecessary prostate MRI after negative biopsy? Learn how simple markers may guide imaging ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...

Nonetheless, the authors concluded, “Liver biopsy is considered the gold standard for diagnosing MASH and MASLD. While ...

The Cancer Biomarkers Market is poised for robust expansion driven by escalating industry demand, accelerated technological ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

Tommy Robertson, 63, is a retired policeman from Renfrewshire, whose life was thrown into chaos after he learnt he had ...